Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (2456)	3/31/2000 10:24:00 AM
From: Mark Marcellus	Respond to of 5582

Mike, after all your history with GUMM, this doesn't raise any alarm bells? After intimations from the company that the Zicam "story" may be a little disappointing this quarter, we get a brand new "story" about a new product that will definitely, positively be a big seller and will blow the stock price through the roof. Once more, it sounds like deja vu all over again. What's next? Maybe someone accidently spilled some Zicam when applying it after a shower, and discovered that the gel matrix is an effective agent against erectile dysfunction. Maybe the clinical studies on that one are being done as we speak. It looks like there are no limits to the wonderful properties of the gel matrix. BTW, where's Howie these days? He's been awfully quiet lately.